Description
To successfully treat tuberculosis it is an absolute necessity that the antimicrobial agents used reaches the site of infection in sufficient amounts. This webinar will discuss the link between drug doses and treatment outcome, the main pharmacokinetic processes, site-of-disease pharmacokinetics in pulmonary TB, combination treatment and drug-drug interactions, and the population approach using mathematical models. The target audience includes healthcare professionals, decision makers, policy makers, researchers, and the TB community.